Recent advances in identifying and validating drug targets in trypanosomes and leishmanias
- 1 February 1999
- journal article
- review article
- Published by Elsevier in Trends in Microbiology
- Vol. 7 (2) , 82-88
- https://doi.org/10.1016/s0966-842x(98)01433-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Prospects for Antiparasitic DrugsJournal of Biological Chemistry, 1998
- The GPI-Phospholipase C of Trypanosoma brucei Is Nonessential But Influences Parasitemia in MiceThe Journal of cell biology, 1997
- Gene disruptions indicate an essential function for the LmmCRK1 cdc2-related kinase of Leishmania mexicanaMolecular Microbiology, 1996
- Creation of Homozygous Mutants of Leishmania donovani with Single Targeting ConstructsPublished by Elsevier ,1996
- Procyclic Trypanosoma brucei cell lines deficient in ornithine decarboxylase activityMolecular and Biochemical Parasitology, 1996
- Cloning of an avermectin-sensitive glutamate-gated chloride channel from Caenorhabditis elegansNature, 1994
- Null mutants for the lmcpa cysteine proteinase gene in Leishmania mexicanaMolecular and Biochemical Parasitology, 1994
- Inhibition of the glycolytic enzymes in the trypanosome: An approach in the development of new leads in the therapy of parasitic diseasesPharmacology & Therapeutics, 1993
- METABOLISM AND FUNCTIONS OF TRYPANOTHIONE IN THE KINETOPLASTIDAAnnual Review of Microbiology, 1992
- Gene replacement in parasitic protozoaNature, 1990